Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
about
Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Fibroblast Growth Factor 23 Is ...... The Northern Manhattan Study.
@ast
Fibroblast Growth Factor 23 Is ...... The Northern Manhattan Study.
@en
type
label
Fibroblast Growth Factor 23 Is ...... The Northern Manhattan Study.
@ast
Fibroblast Growth Factor 23 Is ...... The Northern Manhattan Study.
@en
prefLabel
Fibroblast Growth Factor 23 Is ...... The Northern Manhattan Study.
@ast
Fibroblast Growth Factor 23 Is ...... The Northern Manhattan Study.
@en
P2093
P2860
P50
P1433
P1476
Fibroblast Growth Factor 23 Is ...... The Northern Manhattan Study.
@en
P2093
Armando J Mendez
Chuanhui Dong
Clinton B Wright
Janet T DeRosa
Mitchell S V Elkind
Mitsuhiro Yoshita
Myles Wolf
Nirav H Shah
Shonni Silverberg
P2860
P304
P356
10.1161/STROKEAHA.115.012379
P407
P577
2016-03-08T00:00:00Z